Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Initial results in the development of gene therapy for OI reported by NIH

May 11, 1998

Serono introduces Geref for treatment/diagnosis of GHD

May 8, 1998

CP-336156: nonsteroidal estrogen agonist/antagonist with a better profile than estrogen

May 8, 1998

Osiris awarded patent for the use of MSCs in bone marrow regeneration

May 8, 1998

FDA approves improved oral contraceptive agent

May 7, 1998

ArQule and Beth Israel enter collaboration for osteopenic disease drug discovery

May 7, 1998

OCT: suppression of PTH secretion in mouse model of severe parathyroid hyperplasia

May 7, 1998

Research at Kyorin leads to effective blood glucose-lowering agents

May 6, 1998

Signal awarded SBIR phase II grant for osteoporosis research

May 6, 1998

Hemolink cleared by FDA for phase II testing in chronic anemia

May 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...